D-0149-2024 Class III

Recalled by Siegfried Barbera, SL — Barbera Del Valles, N/A

FDA drug recall D-0149-2024 was initiated by Siegfried Barbera, SL on Nov 20, 2023 and is designated Class III. Reason for recall: Failed Dissolution Specifications Affected quantity: 2016.

Recall details

Product Type
Drugs
Report Date
Dec 20, 2023
Initiation Date
Nov 20, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2016

Product description

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0149-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0149-2024. Report a data issue: hello@regdatalab.com.